Cedar Fair (FUN) Stock “Buy” Rating Kept at Stifel Nicolaus; The Price Objective is $77.0; Last Week Adaptimmune Therapeutics plc (ADAP) Coverage

Among 5 analysts covering Adaptimmune Therapeutics PLC (NASDAQ:ADAP), 3 have Buy rating, 1 Sell and 1 Hold. Therefore 60% are positive. Adaptimmune Therapeutics PLC had 5 analyst reports since February 25, 2016 according to SRatingsIntel. The stock has “Buy” rating by Cowen & Co on Tuesday, June 6. SunTrust maintained Adaptimmune Therapeutics plc (NASDAQ:ADAP) on Saturday, November 11 with “Buy” rating. The firm has “Underperform” rating given on Monday, October 24 by Bank of America. The firm earned “Buy” rating on Thursday, February 25 by Citigroup. See Adaptimmune Therapeutics plc (NASDAQ:ADAP) latest ratings:

11/11/2017 Broker: SunTrust Rating: Buy New Target: $10.0 Maintain

Among 10 analysts covering Cedar Fair (NYSE:FUN), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Cedar Fair has $81 highest and $60 lowest target. $72.25’s average target is 7.29% above currents $67.34 stock price. Cedar Fair had 23 analyst reports since August 24, 2015 according to SRatingsIntel. The rating was upgraded by Hilliard Lyons to “Buy” on Monday, August 24. The stock has “Buy” rating by KeyBanc Capital Markets on Monday, October 23. Stifel Nicolaus maintained Cedar Fair, L.P. (NYSE:FUN) on Wednesday, August 2 with “Buy” rating. The firm has “Buy” rating by KeyBanc Capital Markets given on Wednesday, February 14. As per Thursday, November 2, the company rating was maintained by Stifel Nicolaus. The stock has “Outperform” rating by Macquarie Research on Friday, July 8. Stifel Nicolaus initiated the stock with “Buy” rating in Friday, April 21 report. The stock of Cedar Fair, L.P. (NYSE:FUN) has “Buy” rating given on Monday, June 19 by Goldman Sachs. Macquarie Research initiated the stock with “Neutral” rating in Wednesday, December 9 report. The firm has “Equal-Weight” rating given on Tuesday, April 19 by Stephens.

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on the provision of cancer immunotherapy products based on its proprietary SPEAR T-cell platform. The company has market cap of $771.04 million. The Company’s platform enables to identify cancer targets; find and genetically engineer T-cell receptors ; and produce TCR therapeutic candidates for administration to patients. It currently has negative earnings. The companyÂ’s lead program includes NY-ESO-1 and LAGE-1a cancer antigens, which are in Phase I/II clinical trials for patients with solid tumors, as well as hematological cancer types, including synovial sarcoma, multiple myeloma, non-small cell lung cancer (NSCLC), and ovarian cancer; and pilot trial for myxoid round cell liposarcoma.

The stock increased 3.13% or $0.25 during the last trading session, reaching $8.23. About 354,185 shares traded. Adaptimmune Therapeutics plc (NASDAQ:ADAP) has declined 43.56% since February 15, 2017 and is downtrending. It has underperformed by 60.26% the S&P500.

Analysts await Cedar Fair, L.P. (NYSE:FUN) to report earnings on February, 21. They expect $0.21 earnings per share, up 275.00% or $0.33 from last year’s $-0.12 per share. FUN’s profit will be $11.81M for 80.17 P/E if the $0.21 EPS becomes a reality. After $3.38 actual earnings per share reported by Cedar Fair, L.P. for the previous quarter, Wall Street now forecasts -93.79% negative EPS growth.

Investors sentiment decreased to 0.68 in Q3 2017. Its down 0.41, from 1.09 in 2017Q2. It fall, as 18 investors sold Cedar Fair, L.P. shares while 63 reduced holdings. 15 funds opened positions while 40 raised stakes. 27.74 million shares or 1.35% less from 28.12 million shares in 2017Q2 were reported. Capital Lc holds 3,107 shares or 0.07% of its portfolio. Carnegie Capital Asset Lc reported 86,886 shares. Sheets Smith Wealth holds 13,441 shares or 0.22% of its portfolio. Boston Ltd Llc invested in 16,016 shares. Northern Trust Corp has 0% invested in Cedar Fair, L.P. (NYSE:FUN). Neuberger Berman Grp Incorporated Ltd Liability Company owns 5.46 million shares. Epoch Ptnrs Incorporated owns 434,662 shares for 0.09% of their portfolio. Thrivent For Lutherans accumulated 118,560 shares or 0.03% of the stock. Interocean Cap Ltd Limited Liability Company reported 4,800 shares or 0.05% of all its holdings. Zevin Asset Mngmt Limited Com has invested 0.19% in Cedar Fair, L.P. (NYSE:FUN). Bahl & Gaynor owns 10,058 shares. Price T Rowe Md stated it has 0% of its portfolio in Cedar Fair, L.P. (NYSE:FUN). The Ohio-based Winfield Associates Inc has invested 0.96% in Cedar Fair, L.P. (NYSE:FUN). Oppenheimer & Com Inc reported 48,888 shares or 0.08% of all its holdings. Creative Planning has 13,786 shares for 0% of their portfolio.

The stock increased 1.05% or $0.7 during the last trading session, reaching $67.34. About 188,219 shares traded or 69.45% up from the average. Cedar Fair, L.P. (NYSE:FUN) has risen 22.21% since February 15, 2017 and is uptrending. It has outperformed by 5.51% the S&P500.

Since August 24, 2017, it had 0 insider purchases, and 4 sales for $867,040 activity. On Friday, September 15 the insider Ouimet Matthew A sold $129,800.